N6‐methyladenine profiling of low‐input multiplex clinical samples on transcriptome reveals RNA modifications implicated in type 2 diabetes and acute myocardial infarction
Main Authors: | Shanshan Qin, Kun Yang, Shaoqing Han, Yushu Yuan, Jing Mo, Mengyao Xiao, Yin Yang, Yafen Wang, Xin Fang, Fang Wang, Wei Zhang, Song‐Mei Liu, Xiaocheng Weng, Xiang Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.1165 |
Similar Items
-
RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness
by: Huarong Chen, et al.
Published: (2022-07-01) -
N6-methyladenine regulator-mediated RNA methylation modification patterns in immune microenvironment regulation of osteoarthritis
by: Yong Gu, et al.
Published: (2023-01-01) -
MDR: an integrative DNA N6-methyladenine and N4-methylcytosine modification database for Rosaceae
by: Zhao-Yu Liu, et al.
Published: (2019-06-01) -
Significant differences in the degree of genomic DNA N6-methyladenine modifications in Acidithiobacillus ferrooxidans with two different culture substrates.
by: RuTao Lin, et al.
Published: (2024-01-01) -
Exposure to bisphenol A affects transcriptome-wide N6-methyladenine methylation in ovarian granulosa cells
by: Yuxia Zhang, et al.
Published: (2024-03-01)